Immediate Impact
4 from Science/Nature 54 standout
Citing Papers
Epigenetic drugs in cancer therapy
2025 Standout
Cellular ATP demand creates metabolically distinct subpopulations of mitochondria
2024 StandoutNature
Works of Tricia Kunst being referenced
Phase II study of selumetinib, an orally active inhibitor of MEK1 and MEK2 kinases, in KRASG12R-mutant pancreatic ductal adenocarcinoma
2021
Clinical and Molecular Responses in Lung Cancer Patients Receiving Romidepsin
2008
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Tricia Kunst | 167 | 101 | 443 | 106 | 11 | 595 | |
| Ola Hadadeh | 177 | 92 | 337 | 183 | 16 | 663 | |
| Rowan Pritchard‐Jones | 161 | 52 | 412 | 132 | 9 | 579 | |
| Kristen Rodgers | 146 | 139 | 574 | 203 | 13 | 730 | |
| Ulrike Weyer-Czernilofsky | 315 | 77 | 337 | 171 | 17 | 616 | |
| Olaf Klingbeil | 303 | 67 | 404 | 107 | 17 | 644 | |
| Ali E. Yesilkanal | 140 | 74 | 477 | 201 | 10 | 705 | |
| Nils L. Visser | 164 | 65 | 277 | 83 | 12 | 608 | |
| Gina Lee | 221 | 100 | 327 | 197 | 11 | 624 | |
| Xuhong Fu | 167 | 84 | 477 | 134 | 12 | 681 | |
| Tianshui Sun | 130 | 80 | 431 | 173 | 14 | 523 |
All Works
Loading papers...